Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Citi Trends
CTRN
$497M
| $4.04M | ﹤0.01% |
69,835
+14,537
| +26% | +$697K |
|
4302
Lifecore Biomedical
LFCR
$170M
| $4.04M | ﹤0.01% |
769,360
+4,626
| +0.6% | +$23.3K |
|
|
MAZE
4303
Maze Therapeutics
MAZE
$1.33B
| $4.03M | ﹤0.01% |
135,168
-69,663
| -34% | -$1.83M |
|
4304
ReposiTrak
TRAK
$154M
| $4.03M | ﹤0.01% |
447,662
+105,132
| +31% | +$961K |
|
4305
Franklin Senior Loan ETF
FLBL
$870M
| $4.03M | ﹤0.01% |
175,650
-48,403
| -22% | -$1.11M |
|
4306
NN Inc
NNBR
$277M
| $4.02M | ﹤0.01% |
1,120,202
-415,864
| -27% | -$1.03M |
|
4307
MiMedx Group
MDXG
$692M
| $4.02M | ﹤0.01% |
1,043,286
+230,544
| +28% | +$841K |
|
|
AVEX
4308
AEVEX Corp
AVEX
$1.16B
| $4.01M | ﹤0.01% |
+191,938
| New | +$4.98M |
|
4309
Cannae Holdings
CNNE
$673M
| $4.01M | ﹤0.01% |
278,236
+24,191
| +10% | +$329K |
|
4310
TIM SA
TIMB
$9.04B
| $4M | ﹤0.01% |
186,937
-41,372
| -18% | -$986K |
|
|
GNT
4311
GAMCO Natural Resources, Gold & Income Trust
GNT
$151M
| $4M | ﹤0.01% |
491,113
-20,645
| -4% | -$174K |
|
4312
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$745M
| $3.99M | ﹤0.01% |
94,031
-1,425
| -1% | -$59.8K |
|
|
PWRD
4313
TCW Transform Systems ETF
PWRD
$1.46B
| $3.98M | ﹤0.01% |
32,376
+30,917
| +2,119% | +$3.45M |
|
4314
Richardson Electronics
RELL
$249M
| $3.98M | ﹤0.01% |
209,402
+27,837
| +15% | +$435K |
|
4315
Northrim BanCorp
NRIM
$570M
| $3.98M | ﹤0.01% |
143,496
-50,695
| -26% | -$1.26M |
|
4316
Sana Biotechnology
SANA
$973M
| $3.98M | ﹤0.01% |
1,139,782
-320,233
| -22% | -$1.03M |
|
|
BRW
4317
Saba Capital Income & Opportunities Fund
BRW
$318M
| $3.98M | ﹤0.01% |
605,349
-36,828
| -6% | -$248K |
|
|
YALA
4318
Yalla Group
YALA
$831M
| $3.96M | ﹤0.01% |
722,060
-11,820
| -2% | -$73.2K |
|
|
PPT
4319
Franklin Premier Income Trust
PPT
$318M
| $3.96M | ﹤0.01% |
1,135,071
+2,598
| +0.2% | +$9.05K |
|
4320
ROBO Global Healthcare Technology and Innovation ETF
HTEC
$76.7M
| $3.94M | ﹤0.01% |
105,642
+2,206
| +2% | +$75.6K |
|
4321
Emergent Biosolutions
EBS
$359M
| $3.94M | ﹤0.01% |
469,715
-274,821
| -37% | -$2.3M |
|
4322
Global X Internet of Things ETF
SNSR
$205M
| $3.94M | ﹤0.01% |
78,754
+117
| +0.1% | +$5.45K |
|
|
MUU
4323
Direxion Daily MU Bull 2X ETF
MUU
$3.78B
| $3.92M | ﹤0.01% |
74,820
-974,340
| -93% | -$27.7M |
|
|
PCF
4324
High Income Securities Fund
PCF
$100M
| $3.91M | ﹤0.01% |
715,049
+74,436
| +12% | +$417K |
|
|
PCQ
4325
Pimco California Municipal Income Fund
PCQ
$157M
| $3.9M | ﹤0.01% |
434,930
-36,677
| -8% | -$322K |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.